Finally, the identification of GATA2 and hsa-mir-27a-3p as agents capable of targeting ARG1, CD163, and HIF1A suggest that these two elements may function within the same pathway in both AIS and AMI. The gene discussed is ARG1; the disease is androgen insensitivity syndrome.